BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34209508)

  • 21. NK cell exhaustion in the tumor microenvironment.
    Jia H; Yang H; Xiong H; Luo KQ
    Front Immunol; 2023; 14():1303605. PubMed ID: 38022646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK Cell Metabolism and Tumor Microenvironment.
    Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
    Front Immunol; 2019; 10():2278. PubMed ID: 31616440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and metabolic targeting of natural killer cells to solid tumors.
    Wang J; Matosevic S
    Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intertwined regulation of angiogenesis and immunity by myeloid cells.
    Rivera LB; Bergers G
    Trends Immunol; 2015 Apr; 36(4):240-9. PubMed ID: 25770923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The expression of chemokine receptors in CD56(bright) CD16- natural killer cells and the mechanism of their recruitment in decidua].
    Wu X; Li DJ; Yuan MM; Zhu Y; Wang MY
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1018-23. PubMed ID: 15312539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
    Bödder J; Zahan T; van Slooten R; Schreibelt G; de Vries IJM; Flórez-Grau G
    Front Immunol; 2020; 11():631713. PubMed ID: 33679726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
    Rossi GR; Trindade ES; Souza-Fonseca-Guimaraes F
    Front Immunol; 2020; 11():73. PubMed ID: 32063906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
    Fu LQ; Du WL; Cai MH; Yao JY; Zhao YY; Mou XZ
    Cell Immunol; 2020 Jul; 353():104119. PubMed ID: 32446032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
    Mahaweni NM; Bos GMJ; Mitsiades CS; Tilanus MGJ; Wieten L
    Cancer Immunol Immunother; 2018 Jun; 67(6):861-872. PubMed ID: 29500635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.
    Jacobs B; Gebel V; Heger L; Grèze V; Schild H; Dudziak D; Ullrich E
    Front Immunol; 2021; 12():670540. PubMed ID: 34054844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors.
    Melaiu O; Lucarini V; Cifaldi L; Fruci D
    Front Immunol; 2019; 10():3038. PubMed ID: 32038612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of tumor cells escaping from immune surveillance of NK cells.
    Ge Z; Wu S; Zhang Z; Ding S
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
    Guo SW; Du Y; Liu X
    Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
    J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment.
    Hameed S; Bhattarai P; Dai Z
    Sci China Life Sci; 2018 Apr; 61(4):380-391. PubMed ID: 29607461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.